| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |